Global Atherectomy Devices Market Report Forecast By Product Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), Application (Cardiovascular, Neurovascular, Peripheral Vascular), End User (Hospitals, Ambulatory Care Service, Medical Research Institutes), Countries and Company Analysis 2024-2032

Driving Forces of Atherectomy Devices Market

Increased Peripheral Artery Disease (PAD) Cases

The global atherectomy device market has been expanding owing to an increase in PAD cases brought on by an aging population, rising rates of diabetes, and an increase in obesity. In the United States, PAD affects 8 to 12 million people, primarily those over 50. Of them, 6.5 million people over 40 have a PAD diagnosis. Atherectomy devices represent a significant option in vascular procedures, offering a minimally invasive means of removing arterial plaque. The gadget improves blood flow and lessens weariness and leg pain. These devices assist restore arterial patency by immediately removing or vaporizing the plaque, which improves patient outcomes dramatically in those with severe cases of PAD.

Growing preference for Minimally Invasive Procedures

The market for atherectomy devices is significantly driven by the increasing inclination towards minimally invasive surgical procedures. Compared to open operations, these procedures provide a number of benefits, including less trauma, quicker recovery, a lower risk of complications, and fewer healthcare expenses. Minimally invasive methods have been shown to result in shorter hospital stays, less discomfort following surgery, and faster recovery times for both patients and healthcare staff. The efficiency and safety of atherectomy treatments have also been enhanced by technological developments, increasing their appeal to patients and medical professionals. Patient preferences are given priority in patient-centric care and collaborative decision-making processes, which encourages healthcare professionals to offer atherectomy operations and fuels the market for atherectomy equipment.

Technological Advancements

One of the key drivers of growth for the atherectomy devices market is technological advances. Device performance improvements, like the creation of more accurate and efficient systems, have enhanced plaque removal and decreased arterial damage. Better vision and control during procedures are made possible by enhanced safety features, such as sophisticated imaging and navigation systems, which reduce hazards and improve results.

Devices are now less intrusive thanks to miniaturization, which promotes quicker healing and fewer problems. The combination of other technologies, like as drug-eluting parts and sophisticated imaging, has improved patient outcomes and efficacy even more. Furthermore, improvements in design and materials have led to the creation of more robust, biocompatible devices that are adaptable to a range of clinical situations. Furthermore, ongoing product development and commercialization are anticipated to fuel the market's expansion. Royal Philips introduced peripheral and coronary artery applications, such as the Nexcimerlaser system, in Orlando, Florida, in November 2021. The Nexcimer, a revolutionary laser system from Philips, makes lead extraction and coronary and peripheral atherectomy treatments as easy as plugging and playing.

North America Atherectomy Devices Market

It is anticipated that North America will control a sizeable portion of the market. The market for atherectomy devices is expanding in North America due to a number of factors, including the growing availability of atherectomy system reimbursements, the use of atherectomy systems by medical professionals, the high number of patients with peripheral and coronary artery diseases, and an increase in clinical trials that assess the therapeutic efficacy of atherectomy systems in the treatment of particular diseases.

Regardless of gender, race, or ethnicity, heart disease is the leading cause of death in the United States, according to the CDC's February 2022 update. The most common type of heart disease is coronary heart disease (CHD), also known as coronary artery disease, which is characterized by the development of cholesterol blockages in the walls of the coronary arteries or excessive narrowing of the coronary arteries, which can consequence in stroke or heart attack. As a result, the demand for atherectomy treatments is expected to rise in the area due to the increased prevalence of heart illnesses, which is predicted to fuel growth in the analyzed market over the forecast period.

Additionally, the main causes of this dominance are an appropriate reimbursement environment and a large number of FDA-approved devices. As an illustration, in October 2021, Becton, Dickinson, and Company (BD) declared that the U.S. FDA has granted its 510(k) approval for additional indications for the Rotarex Atherectomy System.

Global Atherectomy Devices Company Analysis

The key players in atherectomy devices industry are Boston Scientific Corporation, Inc., Abbott Laboratories, Medtronic plc, Cardinal Health, Terumo Corporation, Integer Holdings Corporation, Becton, Dickinson and Company an AngioDynamics Inc.

Global Atherectomy Devices Company News

November 2023- In order to give surgical teams safe and practical instrument access in the operating theater, Cardinal Health announced the launch of their SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets in the United States.

August 2022- The Auryon Atherectomy System has received 510(k) approval for an expanded indication, which now includes arterial thrombectomy, according to AngioDynamics, Inc.

February 2022- The critical clinical trial to assess the safety and efficacy of the DABRA excimer laser system as an atherectomy tool for the treatment of peripheral artery disease has enrolled 95 individuals, according to RA Medical Systems.

Product Type – Market breakup in 4 viewpoints:

1. Directional Atherectomy
2. Rotational Atherectomy
3. Orbital Atherectomy
4. Laser Atherectomy

Application – Market breakup in 3 viewpoints:

1. Cardiovascular
2. Neurovascular
3. Peripheral Vascular

End User – Market breakup in 3 viewpoints:

1. Hospitals
2. Ambulatory Care Service
3. Medical Research Institutes

Countries – Market breakup in 25 viewpoints:

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherland
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

All the key players have been covered from 4 Viewpoints:

• Business Overview
• Key Persons
• Recent Development & Strategies
• Financial Insights

Key Players Analysis:

1. Boston Scientific Corporation, Inc.
2. Abbott Laboratories
3. Medtronic plc
4. Cardinal Health
5. Terumo Corporation
6. Integer Holdings Corporation
7. Becton, Dickinson and Company
8. AngioDynamics Inc.

Report Details: